Search Results - Glaucoma Today

Research Update

Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again)

A review of nicotinamide treatment for neuroprotection.

Flora Hui, PhD, and Pete A. Williams, PhD

Peer Review

Normal-Tension Glaucoma: Pathogenesis

The first in a two-part series on this multifactorial disease subtype.

Arpine Barsegian, MD

Health Care

Myopia: A Global Epidemic

An overview of the problem and efforts to address it.

Neesurg Mehta, MD, and Angie E. Wen, MD

Editorial Spotlight: Research Updates

Targeting Metabolic Vulnerabilities for Neuroprotection in Glaucoma

B₃ or not B₃? That is the question.

Pete A. Williams, PhD, and Jonathan G. Crowston, MBBS, FRCOphth, FRANZCO, PhD

Data-Driven Diagnostic Use

With AI and deep learning, the future is bright, but collaboration among investigators will be required.

Felipe A. Medeiros, MD, PhD

Artificial Intelligence, Big Data, and Medical Analytics

Moving toward the automatic diagnosis of glaucoma.

Lama A. Al-Aswad, MD, MPH

Glaucoma Drugs in the Pipeline

Physicians share which coming therapies they are most eager to use in their practices.

Malik Y. Kahook, MD; Paul L. Kaufman, MD; Robert J. Noecker, MD, MBA; and Nathan M. Radcliffe, MD

How Valuable Is Anterior Segment Imaging?

Imaging devices are useful for further screening after first-line diagnostic assessment.

Shan Lin, MD

Therapeutics Update

Novel Risk Factors for Glaucoma

Research suggests that many issues other than IOP may play a role in the pathophysiology of glaucoma.

Shan Lin, MD

Therapeutics Update

A Medical Approach to Forming a Complete Eyelid Crease

Topical prostaglandins may be a viable nonsurgical option for Asian patients who desire a double eyelid crease.

Julia Song, MD

Technology Today

Measuring Macular Thickness in Glaucoma

Clinicians must be aware of important differences in the macular imaging protocols of the commercially available optical coherence tomography systems.

Ahmad A. Aref, MD

Technologies for Analyzing the Optic Disc, RNFL, and Macula

Victor Y. Chang, MD, Terry Kim, MD, Neil T. Choplin, MD, and Paul H. Artes, PhD

Developments in Neuroprotection

Novel neuroprotective agents and their mechanisms.

Daniel Hwang, MA; Li Wu, MD; and James C. Tsai, MD

Developments in Neuroprotection

Novel neuroprotective agents and their mechanisms.

Daniel Hwang, MA; Li Wu, MD; and James C. Tsai, MD